Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Family with sequence similarity 21, member E, pseudogene (FAM21EP), is a transcribed unprocessed pseudogene in the human genome[7][9]. Pseudogenes are genomic elements similar in sequence to known genes but are nonfunctional, usually due to disabling mutations or absence of regulatory elements[8][6]. FAM21EP does not encode a functional protein and does not belong to receptor, enzyme, transporter, or any established druggable molecular class. There is no established association with therapeutic targeting, disease mechanisms, or clinical use. The closest protein-coding relative is WASHC2A, located nearby in the genome[7]. The designation "family with sequence similarity 21, member A pseudogene" is often confused or interchanged with "member E," as per various database aliases, but the evidence supports that both refer to a pseudogene with no recognized biological function or therapeutic relevance[1][5][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 21, member E, pseudogene (FAM21EP).